China approves Brii Bio’s antibody combination to neutralise Covid-19
Brii Bio announces amubarvimab/romlusevimab combination received approval from NMPA
Brii Bio announces amubarvimab/romlusevimab combination received approval from NMPA
Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow
The kit preserves viral nucleic acids in a non-hazardous stabilization solution that inactivates common respiratory viruses for safer sample collection
Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian market
Subscribe To Our Newsletter & Stay Updated